Comparison of Two Adalimumab Treatment Schedule Strategies for Moderate-to-Severe Crohn's Disease: Results From the CHARM Trial

The American Journal of Gastroenterology - Tập 104 Số 5 - Trang 1170-1179 - 2009
Jean–Frédéric Colombel1, William J. Sandborn2, Paul Rutgeerts3, Michael A. Kamm4, Andrew P. Yu5, Eric Q. Wu5, Paul Pollack6, Kathleen G. Lomax6, Jingdong Chao7, Parvez Mulani7
1Department of Hepatogastroenterology, Hôpital Claude Huriez, Centre Hospitalier Universitaire de Lille, Lille, France
2Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA
3Department of Gastro-Enterologie, University Hospital of Gasthuisberg, Leuven, Belgium
4Department of Medicine, St Vincent's Hospital & Melbourne University, Melbourne, Victoria, Australia
5Analysis Group Inc., Boston, Massachusetts, USA
6Medical Affairs—Immunology, Abbott Laboratories, Parsippany, New Jersey, USA
7Global Health Economics and Outcomes Research, Abbott Laboratories, Abbott Park, Illinois, USA.

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1053/j.gastro.2006.11.041

10.1053/j.gastro.2003.11.014

Irvine EJ, 1994, Gastroenterology, 106, 287, 10.1016/0016-5085(94)90585-1

Miettinen O, 1976, Am J Epidemiol, 103, 226, 10.1093/oxfordjournals.aje.a112220

10.1046/j.1572-0241.2003.04010.x

Hay JW, 1992, J Clin Gastroenterol, 14, 309, 10.1097/00004836-199206000-00009

10.1111/j.1572-0241.2000.01779.x

10.2165/00019053-200220100-00001

Thông tin
Thông tin xuất bản

The American Journal of Gastroenterology

Tập 104 Số 5

1170-1179

Thông tin tác giả